Differences on difficult issues such as Chinese industrial policy and intellectual property regimes remain vast — and tough negotiations now lie ahead.
A commission set up by Congress says Chinese authorities are not doing enough to halt the flow of the synthetic opioid fentanyl and related chemicals into the U.S.